Responsiveness of human polymorphonuclear cells (PMNL) to stimulation by a mannoprotein fraction (MP-F2) of Candida albicans; enhanced production of IL-6 and tumour necrosis factor-alpha (TNF-α) by MP-F2-stimulated PMNL from HIV-infected subjects

Clinical and Experimental Immunology

Volumn 107, Issue 3, 1997, Pages 451-457

  Torosantucci, A ^a   Chiani, P ^a   Quinti, I ^b   Ausiello, C M ^a   Mezzaroma, I ^b   Cassone, A ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Candida albicans; Cytokines; HIV; Mannoprotein; Polymorphonuclear cells

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MANNOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANDIDA ALBICANS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUTROPHIL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0031055431     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.2851176.x     Document Type: Article

References (31)

1. Murphy J. The neutrophil. New York: Plenum Medical Books, 1976.
2. Thomas EL, Lehrer RI, Rest RF. Human neutrophil antimicrobial activity. Rev Infect Dis 1988; 10:S450-6.
3. Odds FC. Candida and candidosis. London: Bailllere-Tindall, 1988.
4. Cassatella MA. The production of cytokines by polymorphonuclear neutrophil. Immunol Today 1995; 16:21-26.
5. Lloyd AR, Oppenheim JJ. Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol Today 1992; 13:169-72.
6. Djeu JY, Blanchard DK, Halkias D, Friedman H. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-γ and tumor necrosis factor. J Immunol 1986; 137:2980-4.
7. Djeu JY, Serbousek D, Blanchard DK. Release of tumor necrosis factor by human polymorphonuclear leukocytes. Blood 1990; 76:1405-9.
8. Palma C, Cassone A, Serbousek D, Pearson CA, Djeu JY. Lactoferrin release and interleukin-1, interleukin-6, and tumor necrosis factor production by human polymorphonuclear cells stimulated by various lipopolysaccharides: relationship to growth inhibition of Candida albicans. Infect Immun 1992; 60:4604-11.
9. Cassone A, Marconi P, Bistoni F, Mattia E, Sbaraglia G, Garaci E, Bonmassar E. Immunoadjuvant effects of Candida albicans and its cell wall fractions in a mouse lymphoma model. Cancer Immunol Immunother 1981; 10:181-8.
10. Cassone A, Torosantucci A. Immunological moieties of the cell wall. In: Prasad RW, ed. The molecular biology of Candida albicans. New York: Raven Press, 1991:89-107.
11. Torosantucci A, Palma C, Boccanera M, Ausiello CM, Spagnoli GC, Cassone A. Lymphoproliferation and cytotoxic responses of human peripheral blood mononuclear cells to mannoprotein constituents of Candida albicans. J Gen Microbiol 1990; 136:2155-63.
12. Palma C, Serbousek D, Torosantucci A, Cassone A, Djeu JY. Identification of a mannoprotein fraction from Candida albicans that enhances human polymorphonuclear leukocyte (PMNL) functions and stimulates lactoferrin in PMNL inhibition of candidal growth. J Infect Dis 1992; 166:1103-12.
13. Cassone A, Palma C, Djeu JY, Aiuti F, Quinti I. Anticandidal activity and interleukin-1β and interleukin-6 production by polymorphonuclear leukocytes are preserved in subjects with AIDS. J Clin Microbiol 1993; 31:1354-7.
14. Imam I, Carpenter CCJ, Mayer KH, Fisher A, Stein M, Danforth S. Hierarchical pattern of mucosal Candida infections in HIV-seropositive women. Am J Med 1990; 89:142-6.
15. Klein RS, Harris CA, Butkus Small B, Moll B, Lesser M, Friedland GH. Oral candidiasis in high risk patient as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984; 311:354-6.
16. Fauci AS. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 1993; 262:1011-8.
17. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Ann Biochem 1987; 162:156-9.
18. Urbani F, Maleci A, La Sala A, Lande R, Ausiello CM. Defective expression of interferon-γ, granulocyte-macrophage colony stimulating factor, tumor necrosis factor α and interleukin 6 in activated peripheral blood lymphocytes from glioma patients. J Interfer Cytok Res 1995; 5:421-9.
19. Ehlers S, Smith KA. Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory. J Exp Med 1991; 173:25-36.
20. Brenner CA, Tam AW, Nelson PA. Message amplification phenotyping (mapping): a technique to simultaneously measure multiple mRNAs from small numbers of cells. Biotechniques 1989; 7:1096-103.
21. Mossman TR. Properties and functions of interleukin-10. Adv Immunol 1995; 56:1-26.
22. Matsuyama T, Kobayashi N, Yamamoto N. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 1991; 5:1405-17.
23. Roulston A, Lin R, Beauparlant P, Wainberg MA, Hiscott J. Regulation of HIV type 1 and cytokine gene expression by NF-kb transcription factors. Microbiol Rev 1995; 59:481-505.
24. Poli G, Fauci AS. The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Res Hum Retrovir 1992; 8:191-207.
25. Ho J, He S, Hu A et al. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patient's mononuclear cells and cell lines: an in vitro model for HIV transmission facilitated by Chlamydia trachomatis. J Exp Med 1995; 181:1493-505.
26. Birx DL, Redfield RR, Tencer K, Fowler A, Burke DS, Tosato G. Induction of interleukin-6 during human immunodeficiency virus infection. Blood 1990; 76:2303-10.
27. Breen EC, Rezai AR, Nokajima K et al. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990; 144:480-4.
28. Marfaing-Koka A, Aubin J, Grangeot-Keros L et al. In vivo role of IL-6 on the viral load and on immunological abnormalities of HIV-infected patients. J AIDS Hum Retrovir 1996; 11:59-68.
29. Ladhevirta J, Maury CP, Teppo AM, Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988; 855:289-91.
30. Agresti L, De Bernardis F, Mondello F et al. Clinical and mycological evaluation of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS patients. Eur J Epidemiol 1994; 10:17-22.
31. Blasi E, Pitzurra L, Bartoli A, Puliti M, Bistoni F. Tumor necrosis factor as an autocrine and paracrine signal controlling the macrophage secretory response to Candida albicans. Infect Immun 1994; 62: 1199-206.